Published in the same year as the GUIDE-IT Echo substudy, the PROVE-HF study showed that reduction in NT-proBNP after sacubitril-valsartan use was weakly correlated with improved cardiac structure and function at 6- and 12-months follow-up. This evidence concerns the gene NPPB and hydrops fetalis.